Blue Owl Capital Holdings LP
Position in AQST — Aquestive Therapeutics, Inc.
CIK 1858703
New York, NY
Position in AQST
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,922,597
-$1,671,320 QoQ
Shares Held
942,932
-30.0% QoQ
Ownership
0.751%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#19
of 184 holders
Holding Since
Mar 2024
10 quarters on record
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Blue Owl Capital Holdings LP holds $4,707,514 across 2 Drug Manufacturers - Specialty & Generic names. AQST ranks #1 (83.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AQST |
Aquestive Therapeutics, Inc.
This page
|
942,932 | $3,922,597 | |
| 2 | ADCT |
ADC Therapeutics SA
|
733,568 | $784,917 |
All Filings in AQST
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,922,597 | 942,932 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $5,593,917 | 1,347,932 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,391,500 | 525,000 | Shares | Defined | 2026-02-20 | |
| 2025-09-30 | $6,987,500 | 1,250,000 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,045,200 | 920,000 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,668,000 | 920,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,204,000 | 900,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,100,500 | 1,225,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,964,000 | 1,140,000 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $3,727,500 | 875,000 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||